Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly.

Ma C, Yin Z, Zhu P, Luo J, Shi X, Gao X.

Mol Neurodegener. 2017 Mar 7;12(1):24. doi: 10.1186/s13024-017-0167-y.

2.

Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease.

Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL.

Neuropsychiatr Dis Treat. 2016 Nov 10;12:2913-2920. eCollection 2016.

3.

Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study.

He Q, Li Q, Zhao J, Wu T, Ji L, Huang G, Ma F.

Lipids Health Dis. 2016 Sep 5;15(1):146. doi: 10.1186/s12944-016-0320-6.

4.

Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial.

Cooper SA, Ademola T, Caslake M, Douglas E, Evans J, Greenlaw N, Haig C, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sirisena C, Sullivan F.

Trials. 2016 Jul 29;17:370. doi: 10.1186/s13063-016-1370-9.

5.

Nonlinear associations between plasma cholesterol levels and neuropsychological function.

Wendell CR, Zonderman AB, Katzel LI, Rosenberger WF, Plamadeala VV, Hosey MM, Waldstein SR.

Neuropsychology. 2016 Nov;30(8):980-987. Epub 2016 Jun 9.

PMID:
27280580
6.

Serum Cholesterol Levels within the High Normal Range Are Associated with Better Cognitive Performance among Chinese Elderly.

Lv YB, Yin ZX, Chei CL, Brasher MS, Zhang J, Kraus VB, Qian F, Shi XM, Matchar DB, Zeng Y.

J Nutr Health Aging. 2016 Mar;20(3):280-7. doi: 10.1007/s12603-016-0701-6..

7.

Elevated levels of serum cholesterol are associated with better performance on tasks of episodic memory.

Leritz EC, McGlinchey RE, Salat DH, Milberg WP.

Metab Brain Dis. 2016 Apr;31(2):465-73. doi: 10.1007/s11011-016-9797-y. Epub 2016 Feb 12.

8.

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men.

Ma C, Li J, Bao Z, Ruan Q, Yu Z.

Biomed Res Int. 2015;2015:481621. doi: 10.1155/2015/481621. Epub 2015 Nov 23.

9.

Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans.

Hendrie HC, Hake A, Lane K, Purnell C, Unverzagt F, Smith-Gamble V, Murrell J, Ogunniyi A, Baiyewu O, Callahan C, Saykin A, Taylor S, Hall K, Gao S.

Ethn Dis. 2015 Aug 7;25(3):345-54. doi: 10.18865/ed.25.3.345.

10.

Medicinal Plants and New Concerns in Statin Consumption.

Nasri H, Rafieian-Kopaei M.

Iran J Public Health. 2013 Sep;42(9):1071-2. No abstract available.

11.

Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study.

Xia W, Zhang B, Yang Y, Wang P, Yang Y, Wang S.

Lipids Health Dis. 2015 May 21;14:47. doi: 10.1186/s12944-015-0046-x.

12.

Voluntary cognitive screening: characteristics of participants in an Asian setting.

Ho V, Zainal NH, Lim L, Ng A, Silva E, Kandiah N.

Clin Interv Aging. 2015 Apr 20;10:771-80. doi: 10.2147/CIA.S73563. eCollection 2015.

13.
14.

Statins and brain integrity in older adults: secondary analysis of the Health ABC study.

Nadkarni NK, Perera S, Hanlon JT, Lopez O, Newman AB, Aizenstein H, Elam M, Harris TB, Kritchevsky S, Yaffe K, Rosano C.

Alzheimers Dement. 2015 Oct;11(10):1202-11. doi: 10.1016/j.jalz.2014.11.003. Epub 2015 Jan 12.

15.

Cholesterol balance in prion diseases and Alzheimer's disease.

Hannaoui S, Shim SY, Cheng YC, Corda E, Gilch S.

Viruses. 2014 Nov 20;6(11):4505-35. doi: 10.3390/v6114505. Review.

16.

Molecular mechanisms underlying the effects of statins in the central nervous system.

McFarland AJ, Anoopkumar-Dukie S, Arora DS, Grant GD, McDermott CM, Perkins AV, Davey AK.

Int J Mol Sci. 2014 Nov 10;15(11):20607-37. doi: 10.3390/ijms151120607. Review.

17.

The relationship between cholesterol and cognitive function is homocysteine-dependent.

Cheng Y, Jin Y, Unverzagt FW, Su L, Yang L, Ma F, Hake AM, Kettler C, Chen C, Liu J, Bian J, Li P, Murrell JR, Hendrie HC, Gao S.

Clin Interv Aging. 2014 Oct 23;9:1823-9. doi: 10.2147/CIA.S64766. eCollection 2014.

18.

Deconstructing racial differences: the effects of quality of education and cerebrovascular risk factors.

Carvalho JO, Tommet D, Crane PK, Thomas ML, Claxton A, Habeck C, Manly JJ, Romero HR.

J Gerontol B Psychol Sci Soc Sci. 2015 Jul;70(4):545-56. doi: 10.1093/geronb/gbu086. Epub 2014 Aug 5.

19.

Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme.

Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, Deary IJ, Elliott J, Gunnell D, Harris SE, Kivimaki M, Kumari M, Martin RM, Power C, Sayer AA, Starr JM, Kuh D, Day IN; HALCyon Study Team..

Age (Dordr). 2014;36(4):9673. doi: 10.1007/s11357-014-9673-9. Epub 2014 Jul 30.

20.

Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.

Cooper SA, Caslake M, Evans J, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sullivan F.

Trials. 2014 Jun 3;15:202. doi: 10.1186/1745-6215-15-202.

Supplemental Content

Support Center